Page last updated: 2024-10-23

astemizole and Syncope

astemizole has been researched along with Syncope in 1 studies

Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.

Syncope: A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gowardman, J1

Other Studies

1 other study available for astemizole and Syncope

ArticleYear
QT prolongation on the standard dose of astemizole.
    The New Zealand medical journal, 1996, Feb-09, Volume: 109, Issue:1015

    Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Astemizole; Electrocardiography; Female; Histamine H1

1996